Rani Therapeutics Holdings, Inc. (RANI) Deferred Tax Assets, Valuation Allowance USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rani Therapeutics Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2023.
  • Rani Therapeutics Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $61 M, a 15.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $61 M +$8.18 M +15.5% Dec 31, 2023 10-K 2024-03-20
Q4 2022 $52.8 M +$24.1 M +84.2% Dec 31, 2022 10-K 2024-03-20
Q4 2021 $28.7 M +$28.3 M +7670% Dec 31, 2021 10-K 2023-03-22
Q4 2020 $369 K Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.